| Study |
Reference |
|
Albertini, 2023
|
Albertini Assessment of Severity of Long QT Syndrome Phenotype and Risk of Fetal Death. J Am Heart Assoc 2023; 12:e029407
|
|
Bateman, 2016
|
Bateman Late Pregnancy Beta Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. Pediatrics 2016; 138:
|
|
Bayliss, 2002
|
Bayliss Anti-hypertensive drugs in pregnancy and fetal growth: evidence for 'pharmacological programming' in the first trimester? Hypertens Pregnancy 2002; 21:161-74
|
|
Caton, 2009
|
Caton Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 2009; 54:63-70
|
|
Darcie, 2004
|
Darcie Glycemia in newborns of hypertensive mothers
according to maternal treatment. Rev. Hosp Clin. 2004, 59, 244–250
|
|
Delteil, 2024
|
Delteil Beta-blockers and pregnancy - An EFEMERIS study Scientific report. 2024: 1-67.
|
|
Duan, 2018
|
Duan Beta-blocker subtypes and risk of low birth weight in newborns. J Clin Hypertens (Greenwich) 2018; 20:1603-1609
|
|
Fitton (Controls unexposed, disease free), 2020
|
Fitton In Utero Antihypertensive Medication Exposure and Neonatal Outcomes: A Data Linkage Cohort Study. Hypertension 2020; 75:628-633
|
|
Fitton (Controls unexposed, sick), 2020
|
Fitton In Utero Antihypertensive Medication Exposure and Neonatal Outcomes: A Data Linkage Cohort Study. Hypertension 2020; 75:628-633
|
|
Ishibashi, 2017
|
Ishibashi Arrhythmia risk and ?-blocker therapy in pregnant women with long QT syndrome. Heart 2017; 103:1374-1379
|
|
Lydakis, 1999
|
Lydakis Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999; 12:541-7
|
|
Orbach, 2013
|
Orbach H Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol 2013;208:301.e1-6
|
|
Tanaka, 2016
|
Tanaka Beta-Blockers and Fetal Growth Restriction in Pregnant Women With Cardiovascular Disease. Circ J 2016; 80:2221-6
|
|
Van Zutphen, 2014
|
Caton Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A Clin Mol Teratol 2008; 82:34-40 Van Zutphen AR Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol 2014;123:309-17
|
